First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Helicobacter. 2015 Apr;20(2):106-13. doi: 10.1111/hel.12183. Epub 2015 Jan 12.
Patients with duodenal ulcer have a reduced risk of developing gastric cancer compared to those without. Recently, the prostate stem cell antigen (PSCA) rs2294008 C>T polymorphism was found to be associated with different pathogenesis of duodenal ulcer and gastric cancer developments. However, whether PSCA rs2294008 C>T polymorphism is associated with severity of gastric mucosal atrophy is unclear. We examined the influence of the PSCA rs2294008 C>T polymorphism on susceptibility to H. pylori-related diseases and the relationships between PSCA polymorphism and gastric mucosal atrophy.
PSCA rs2294008 C>T polymorphism was assessed in H. pylori-positive Japanese patients (n = 488) with noncardia gastric cancer (n = 193), gastric ulcer (n = 84), duodenal ulcer (n = 61), and atrophic gastritis (n = 150), as well as in H. pylori-negatives (n = 266).
Frequency of PSCA rs2294008 C/C genotype in duodenal ulcer was 36.1%, which was significantly higher than those with gastric cancer (12.4%), gastric ulcer (19.0%), gastritis (10.7%), and H. pylori-negatives (19.5%) (p < .001). Compared with duodenal ulcer, having the T allele significantly increased the risk of gastric cancer (OR: 3.97, 95% CI: 2.02-7.80; p < .001), gastric ulcer (2.40, 1.13-5.10; p = .023), and gastritis (4.72, 2.26-9.86; p < .001). Mean pepsinogen (PG) I/PG II ratio in T allele carriers (2.17 ± 0.75) was significantly lower than that in C/C genotype (3.39 ± 1.27, p < .001).
The PSCA rs2294008 C>T polymorphism is associated with differing susceptibilities to H. pylori-associated diseases. The PSCA rs2294008 C>T polymorphism may be acting through induction of gastric mucosal atrophy, finally leading to development of gastric ulcer and gastric cancer in PSCA rs2294008 T allele carriers, but not duodenal ulcer.
与无十二指肠溃疡患者相比,十二指肠溃疡患者发生胃癌的风险较低。最近,发现前列腺干细胞抗原(PSCA)rs2294008 C>T 多态性与十二指肠溃疡和胃癌发展的不同发病机制有关。然而,PSCA rs2294008 C>T 多态性是否与胃黏膜萎缩的严重程度有关尚不清楚。我们研究了 PSCA rs2294008 C>T 多态性对幽门螺杆菌相关疾病易感性的影响,以及 PSCA 多态性与胃黏膜萎缩之间的关系。
评估了幽门螺杆菌阳性的日本患者(n = 488)中 PSCA rs2294008 C>T 多态性,这些患者患有非贲门胃癌(n = 193)、胃溃疡(n = 84)、十二指肠溃疡(n = 61)和萎缩性胃炎(n = 150),以及幽门螺杆菌阴性患者(n = 266)。
十二指肠溃疡患者 PSCA rs2294008 C/C 基因型的频率为 36.1%,明显高于胃癌(12.4%)、胃溃疡(19.0%)、胃炎(10.7%)和幽门螺杆菌阴性患者(19.5%)(p<.001)。与十二指肠溃疡相比,携带 T 等位基因显著增加了胃癌(OR:3.97,95%CI:2.02-7.80;p<.001)、胃溃疡(2.40,1.13-5.10;p =.023)和胃炎(4.72,2.26-9.86;p<.001)的风险。T 等位基因携带者的胃蛋白酶原(PG)I/PG II 比值(2.17 ± 0.75)明显低于 C/C 基因型(3.39 ± 1.27,p<.001)。
PSCA rs2294008 C>T 多态性与幽门螺杆菌相关疾病的易感性不同。PSCA rs2294008 C>T 多态性可能通过诱导胃黏膜萎缩,最终导致 PSCA rs2294008 T 等位基因携带者发生胃溃疡和胃癌,而不是十二指肠溃疡。